Pharma Focus America: Big Data Analytics – A Revolution in the Pharmaceutical Industry
In this panel discussion, our panelists will explore how big data analytics is reshaping drug…
CertaraSeptember 11, 2023
Methods to Increase Signal Finding in Rare Disease Drug Development
The regulatory landscape for drugs to treat rare diseases is being disrupted. Gleaning from several…
CertaraSeptember 8, 2023
How A Biotech Startup Company Increased Flexibility and Efficiency by Switching to Phoenix Hosted
Discover how a biotech startup enhanced flexibility and efficiency by adopting Phoenix Hosted, streamlining workflows…
CertaraSeptember 8, 2023
The Inflation Reduction Act’s Impact on Drug Development for Rare Diseases
Despite these wins for many patients, the new law is already impacting the discovery and…
CertaraSeptember 1, 2023
RAPS Sponsored Webcast: Plain Language Summaries: Understanding the “Why” Behind the Regulations and Guidance
Plain language regulatory requirements have recently come into effect for the EU and UK. This…
CertaraAugust 30, 2023
Quantification of drug metabolising enzymes and transporter proteins in the paediatric duodenum via LC-MS/MS proteomics using a QconCAT technique
Characterising the small intestine absorptive membrane is essential to enable prediction of the systemic exposure…
CertaraAugust 29, 2023
Certara Launches v11.0 of SEND Explorer
Delivers advanced data analysis and visualization capabilities to support nonclinical scientists PRINCETON, N.J.— August 28,…
CertaraAugust 28, 2023
Payers’ reaction to the IRA’s Medicare Part D Redesign
On August 16, 2022, President Biden signed the Inflation Reduction Act of 2022 (IRA) into…
CertaraAugust 25, 2023
